PANews reported on June 27 that Cathie Wood shared her firm's latest research views on X, pointing out that multi-omics is the most far-reaching application arena for artificial intelligence, and will bring comprehensive structural transformation to the healthcare industry.

AI-powered multi-omics technology can integrate multi-level biological data, enabling early disease screening before any symptoms appear in the human body; at the same time, it can significantly shorten drug R&D timelines, reduce R&D investment, accelerate the rollout of innovative therapies, and fundamentally improve the operational efficiency of the healthcare system.

Cathie Wood assesses that this technology wave will completely transform the operating logic of the healthcare industry, driving the sector to upgrade from the traditional reactive "treatment model" to a proactive health management system, and completing the shift from passive treatment to early prevention.